19-11199530-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020812.4(DOCK6):c.6111G>T(p.Leu2037Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,580,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020812.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOCK6 | NM_020812.4 | c.6111G>T | p.Leu2037Phe | missense_variant | 48/48 | ENST00000294618.12 | NP_065863.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOCK6 | ENST00000294618.12 | c.6111G>T | p.Leu2037Phe | missense_variant | 48/48 | 1 | NM_020812.4 | ENSP00000294618.6 | ||
DOCK6 | ENST00000587734.1 | c.85G>T | p.Glu29* | stop_gained | 2/2 | 5 | ENSP00000468291.1 | |||
DOCK6 | ENST00000587656.6 | c.6216G>T | p.Leu2072Phe | missense_variant | 49/49 | 5 | ENSP00000468638.2 | |||
DOCK6 | ENST00000586702.1 | n.1014G>T | non_coding_transcript_exon_variant | 7/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000306 AC: 6AN: 196366Hom.: 0 AF XY: 0.0000475 AC XY: 5AN XY: 105220
GnomAD4 exome AF: 0.0000105 AC: 15AN: 1428344Hom.: 0 Cov.: 31 AF XY: 0.0000156 AC XY: 11AN XY: 706996
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74484
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.6111G>T (p.L2037F) alteration is located in exon 48 (coding exon 48) of the DOCK6 gene. This alteration results from a G to T substitution at nucleotide position 6111, causing the leucine (L) at amino acid position 2037 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 13, 2022 | This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 2037 of the DOCK6 protein (p.Leu2037Phe). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with DOCK6-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at